Long-term delivery of ivermectin by use of poly(D,L-lactic-co-glycolic)acid microparticles in dogs
- PMID: 15198214
- DOI: 10.2460/ajvr.2004.65.752
Long-term delivery of ivermectin by use of poly(D,L-lactic-co-glycolic)acid microparticles in dogs
Abstract
Objective: To evaluate the potential utility of poly(D,L-lactic-co-glycolic)acid (PLGA) as a long-acting biodegradable drug delivery matrix for ivermectin used in the prevention of heartworm disease in dogs.
Animals: 30 adult female dogs.
Procedure: Microparticle formulations containing 25 weight percent (wt%), 35 wt%, and 50 wt% ivermectin were prepared by an oil-in-water emulsion technique with solvent extraction into excess water. A fourth formulation, consisting of a mixture of 15 wt% and 50 wt% ivermectin microparticles, was blended in a 1:1 ratio to result in a 32.5 wt% ivermectin formulation. Formulations were administered once on Day 0 to groups of 6 dogs at a dose of 0.5 mg of ivermectin/kg, s.c. Half of the dogs in each treatment group and 3 untreated control dogs were infected with Dirofilaria immitis larvae 121 and 170 days after treatment. Six months after infection, dogs were euthanatized and necropsies were performed. Pharmacokinetics and efficacy were investigated.
Results: Analysis of pharmacokinetic data revealed sustained release of ivermectin during at least 287 days in 3 distinct phases: a small initial peak, followed by release of drug through diffusion, and polymer degradation. Untreated control dogs were all infected with heartworms. Heartworms were not found in any of the dogs in the ivermectin-PLGA treated groups. Adverse clinical signs were not observed.
Conclusions and clinical relevance: All formulations were 100% effective in preventing development of adult heartworms. Results indicate that PLGA microparticles are a promising drug delivery matrix for use with ivermectin for the prevention of heartworm disease for at least 6 months after treatment.
Similar articles
-
Pharmacokinetics and efficacy of an ivermectin implant for long-term prevention of Dirofilaria immitis infection in dogs.Parasitol Res. 2017 Jun;116(6):1723-1728. doi: 10.1007/s00436-017-5448-4. Epub 2017 Apr 22. Parasitol Res. 2017. PMID: 28432479 Clinical Trial.
-
Evaluation of a covered-rod silicone implant containing ivermectin for long-term prevention of heartworm infection in dogs.Am J Vet Res. 2006 Sep;67(9):1564-9. doi: 10.2460/ajvr.67.9.1564. Am J Vet Res. 2006. PMID: 16948602 Clinical Trial.
-
Efficacy of long-term monthly administration of ivermectin on the progress of naturally acquired heartworm infections in dogs.Vet Parasitol. 2004 Oct 5;124(3-4):259-68. doi: 10.1016/j.vetpar.2004.06.024. Vet Parasitol. 2004. PMID: 15381305
-
The safety-net story about macrocyclic lactone heartworm preventives: a review, an update, and recommendations.Vet Parasitol. 2005 Oct 24;133(2-3):197-206. doi: 10.1016/j.vetpar.2005.04.005. Epub 2005 Apr 26. Vet Parasitol. 2005. PMID: 16198822 Review.
-
The emergence of macrocyclic lactone resistance in the canine heartworm, Dirofilaria immitis.Parasitology. 2015 Sep;142(10):1249-59. doi: 10.1017/S003118201500061X. Epub 2015 Jun 4. Parasitology. 2015. PMID: 26040450 Review.
Cited by
-
Biodegradable Polymers in Veterinary Medicine-A Review.Molecules. 2024 Feb 17;29(4):883. doi: 10.3390/molecules29040883. Molecules. 2024. PMID: 38398635 Free PMC article. Review.
-
Formulation composition, manufacturing process, and characterization of poly(lactide-co-glycolide) microparticles.J Control Release. 2021 Jan 10;329:1150-1161. doi: 10.1016/j.jconrel.2020.10.044. Epub 2020 Oct 24. J Control Release. 2021. PMID: 33148404 Free PMC article. Review.
-
Current therapeutic applications and pharmacokinetic modulations of ivermectin.Vet World. 2019 Aug;12(8):1204-1211. doi: 10.14202/vetworld.2019.1204-1211. Epub 2019 Aug 8. Vet World. 2019. PMID: 31641298 Free PMC article. Review.
-
Long-acting injectable hormonal dosage forms for contraception.Pharm Res. 2015 Jul;32(7):2180-91. doi: 10.1007/s11095-015-1686-2. Epub 2015 Apr 22. Pharm Res. 2015. PMID: 25899076 Review.
-
Improved antifilarial activity of ivermectin in chitosan-alginate nanoparticles against human lymphatic filarial parasite, Brugia malayi.Parasitol Res. 2013 Aug;112(8):2933-43. doi: 10.1007/s00436-013-3466-4. Epub 2013 Jul 5. Parasitol Res. 2013. PMID: 23828187
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources